Evidence map›Paper›PMID 39285195›Full record

ArticleBlood cancer journal2024

Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia.

Bon-Kwan Koo, Eun-Ji Choi, Ju Hyun Moon, Ji Yun Kim, Hyunkyung Park, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo-Hyung Lee, Eun Kyung Choi and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bon-Kwan KooDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Eun-Ji ChoiDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. eunjichoi@amc.seoul.kr.ORCID 0000-0002-9568-8877
Ju Hyun MoonDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ji Yun KimDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hyunkyung ParkDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Han-Seung ParkDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Yunsuk ChoiDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Jung-Hee LeeDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kyoo-Hyung LeeDepartment of Hematology-Oncology, Ewha Woman's University Medical Center, Mokdong Hospital, Seoul, Republic of Korea.
Eun Kyung ChoiAsan Preclinical Evaluation Center for Cancer Therapeutics, Asan Medical Center, Seoul, Republic of Korea.
Eunji KimR&D Institute, Yungjin Pharmaceutical Co., Ltd, Seoul, Republic of Korea.
Je-Hwan LeeDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-7060-1675
Eun-Hye HurDepartment of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. gracehur@amc.seoul.kr.ORCID 0000-0002-8613-4223

Funding

Asan Institute for Life Sciences, Asan Medical Center 2023IP0053-1Korea Health Industry Development Institute (KHIDI) HI20C1586National Research Foundation of Korea (NRF) NRF-2017R1D1A1B03034544National Research Foundation of Korea (NRF) RS-2023-00274668
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Synergismfms-Like Tyrosine Kinase 3Leukemia, Myeloid, AcuteMutationProtein Kinase InhibitorsAntineoplastic Combined Chemotherapy ProtocolsCyclin-Dependent Kinase-Activating KinaseCyclin-Dependent KinasesHumansCyclin-Dependent Kinase-Activating KinaseCyclin-Dependent KinasesFLT3 protein, humanfms-Like Tyrosine Kinase 3Protein Kinase Inhibitors

Identifiers

PMID39285195
PMCPMC11405686

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.